We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Will Stocks Gain After the Elections? & Earnings from CVS, LLY, HEAR
Read MoreHide Full Article
On today’s episode of Free Lunch, Ryan McQueeney chats with Dave Bartosiak about the near-term outlook for stocks after the midterm elections and the earnings outlook for Turtle Beach ahead of its report. The host also recaps earnings results from CVS, Eli Lilly, and Regeneron.
Free Lunch is presented by Zacks Investment Research. It is streamed live, four times per week, and features breaking news and analysis from Zacks strategists. Free Lunch is available on YouTube, Facebook Live, Twitter, Ustream, and more.
U.S. stocks moved modestly higher in morning trading Tuesday, the same day millions of citizens are heading to the polls to cast votes in the midterm elections.
Wall Street appears to be handicapping a Democratic shift in the House of Representatives, as most opinion polls are calling for the party to take control of the chamber. Those same polls are also predicting that the Republicans will retain their lead in the Senate, meaning we could soon have a split Congress.
Interestingly enough, stocks have historically performed better during periods of Congressional gridlock, and if anything, investors will be happy to move past the uncertainty of the elections themselves. Plus, many of the same fundamental tailwinds and headwinds affecting equity prices will remain, regardless of the federal government’s s partisan makeup.
And as the votes roll in, so too are the Q3 earnings reports. This morning was a busy session for pre-market reports in the broader medical space, with the likes of CVS (CVS - Free Report) , Eli Lilly (LLY - Free Report) , and Regeneron (REGN - Free Report) filing before the bell.
Results from these companies were relatively positive, although mixed in some areas. CVS topped estimates on both lines and said its merger with Aetna would be complete by Thanksgiving, Eli Lilly surpassed EPS projections, and Regeneron crushed profit expectations but missed revenue estimates.
Ryan covers all of these reports and gives his perspective on how Wall Street is feeling about the midterms on today’s show!
Later, he checks in with Dave Bartosiak to continue chatting about the near-term outlook for stocks after the midterms. Dave starts by showing an interesting technical trend that has developed in the Nasdaq (QQQ - Free Report) , where bulls and bears have battled to keep the stock above and below certain moving averages and indicators.
Dave also suggests that part of this battle has to do with the event risk of the midterms, so he explains how and why Wall Street prices in risk when facing these uncertainties.
Finally, Dave highlights Turtle Beach (HEAR - Free Report) , which is scheduled to announce its latest quarterly results after the bell. He touches on the sentiment surrounding the stock and recommends a specific options play for those who are optimistic about the gaming headset maker. Make sure to check out the show to hear more!
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.
Image: Bigstock
Will Stocks Gain After the Elections? & Earnings from CVS, LLY, HEAR
On today’s episode of Free Lunch, Ryan McQueeney chats with Dave Bartosiak about the near-term outlook for stocks after the midterm elections and the earnings outlook for Turtle Beach ahead of its report. The host also recaps earnings results from CVS, Eli Lilly, and Regeneron.
Want more video content from Zacks? Subscribe to Zacks Investment News now!
Free Lunch is presented by Zacks Investment Research. It is streamed live, four times per week, and features breaking news and analysis from Zacks strategists. Free Lunch is available on YouTube, Facebook Live, Twitter, Ustream, and more.
U.S. stocks moved modestly higher in morning trading Tuesday, the same day millions of citizens are heading to the polls to cast votes in the midterm elections.
Wall Street appears to be handicapping a Democratic shift in the House of Representatives, as most opinion polls are calling for the party to take control of the chamber. Those same polls are also predicting that the Republicans will retain their lead in the Senate, meaning we could soon have a split Congress.
Interestingly enough, stocks have historically performed better during periods of Congressional gridlock, and if anything, investors will be happy to move past the uncertainty of the elections themselves. Plus, many of the same fundamental tailwinds and headwinds affecting equity prices will remain, regardless of the federal government’s s partisan makeup.
And as the votes roll in, so too are the Q3 earnings reports. This morning was a busy session for pre-market reports in the broader medical space, with the likes of CVS (CVS - Free Report) , Eli Lilly (LLY - Free Report) , and Regeneron (REGN - Free Report) filing before the bell.
Results from these companies were relatively positive, although mixed in some areas. CVS topped estimates on both lines and said its merger with Aetna would be complete by Thanksgiving, Eli Lilly surpassed EPS projections, and Regeneron crushed profit expectations but missed revenue estimates.
Ryan covers all of these reports and gives his perspective on how Wall Street is feeling about the midterms on today’s show!
Later, he checks in with Dave Bartosiak to continue chatting about the near-term outlook for stocks after the midterms. Dave starts by showing an interesting technical trend that has developed in the Nasdaq (QQQ - Free Report) , where bulls and bears have battled to keep the stock above and below certain moving averages and indicators.
Dave also suggests that part of this battle has to do with the event risk of the midterms, so he explains how and why Wall Street prices in risk when facing these uncertainties.
Finally, Dave highlights Turtle Beach (HEAR - Free Report) , which is scheduled to announce its latest quarterly results after the bell. He touches on the sentiment surrounding the stock and recommends a specific options play for those who are optimistic about the gaming headset maker. Make sure to check out the show to hear more!
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.
See Them Free>>